MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Analysis of LINGO1 and LINGO2 genes in essential tremor and Parkinson’s disease

    N.Y. Abramycheva, M.S. Stepanova, E.Y. Fedotova, E.O. Ivanova, S.N. Illarioshkin (Moscow, Russia)

    Objective: We studied the involvement of LINGO1 and LINGO2 in Russian patients with ET and PD. Background: Genetics of ET is unclear. Three candidate loci…
  • 2016 International Congress

    Comparing tremor- and non-tremor effects of ethanol in patients with essential tremor

    J. Thompson-Westra, G. McCrossin, B. Voller, S. Auh, C. Lungu, S. Tinaz, V. Ramchandani, M. Hallett, D. Haubenberger (Bethesda, MD, USA)

    Objective: To explore the relationship between self-reported non-tremor effects of ethanol and objective tremor severity in Essential Tremor (ET). Background: Ethanol has been demonstrated to…
  • 2016 International Congress

    Modelling spinocerebellar ataxia 15 with iPS cell derived neurons

    S. Wiethoff, C. Arber, S. Wray, Y. Zhi, R. Patani, H. Henry (London, United Kingdom)

    Objective: Here we set out to study the cellular pathology of ITPR1-deletions underlying SCA15 in a human model of iPSC-derived cortical neurons. Background: Spinocerebellar Ataxia…
  • 2016 International Congress

    Cerebellar ataxia and pregnancy

    N. Hidarilak, T. Yacoubian (Birmingham, AL, USA)

    Objective: IVIG is a good treatment for autoimmune cerebellar ataxia (high anti-GAD antibody). Background: IVIG should be considered as a therapy for cerebellar ataxia related…
  • 2016 International Congress

    Novel variants in the SACS gene in a first Central-Eastern European family with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)

    M. Schinwelski, M. Krygier, J. Slawek, M. Zuk, M. Rydzanicz, A. Walczak, P. Stawinski, A. Konkel, M. Sildatke-Bauer, R. Ploski, J. Limon (Gdansk, Poland)

    Objective: To present genetics, clinical description and natural history of the disease in four members of a Polish family with novel variants in the SACS…
  • 2016 International Congress

    GAA expansion with clinic/urodynamic findings in Friedreich’s ataxia with LUTS

    P.N.S. Almeida, A.F.A. Musegante, U. Barroso (Salvador, Brazil)

    Objective: This study correlate the number of GAA repetitions of alleles, the duration of the disease, and the age at the onset of the disease…
  • 2016 International Congress

    Magnetic resonance imaging and pyramidal impairment in Huntington disease

    A. Sanguinetti, S. Lescano, M. Cesarini, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: To identify structural involvement of the corticospinal pathway in Huntington disease (HD) with clinical upper motor neuron signs using diffusion tensor imaging (DTI). Background:…
  • 2016 International Congress

    Striatal molecular alterations in Huntington’s disease gene expansion carriers: A systematic review and meta-analysis of PET studies

    F. Niccolini, G. Pagano, P. Fusar-Poli, A. Wood, L. Mrzljak, C. Sampaio, M. Politis (London, United Kingdom)

    Objective: To systematically examine the evidence of striatal molecular alterations in premanifest and manifest Huntington's disease gene expansion carriers (HDGECs) as measured by Positron emission…
  • 2016 International Congress

    Fast and simple non-invasive screening tool for mitochondrial changes in Huntington’s disease

    P. Dušek, M. Rodinová, I. Lišková, E. Trefilová, Z. Ellederová, J. Klempír, J. Roth, H. Hansíková (Prague, Czech Republic)

    Objective: To use Complex I and Complex IV Human Protein Quantity Dipstick Assay Kits to analyse mitochondrial changes in buccal epithelial cells of patients with…
  • 2016 International Congress

    THK-5351 tau-tracer uptake in patients with clinically diagnosed progressive supranuclear palsy

    S. Schönecker, M. Brendel, J. Havla, G. Höglinger, K. Bötzel, A. Danek, A. Rominger, J. Levin (Munich, Germany)

    Objective: The objective of our study is to investigate characteristics of THK-5351 binding in patients with clinically diagnosed progressive supranuclear palsy (PSP) and correlate tau-tracer…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley